ELIXIR MD, Inc., a pioneer in plastic surgery recovery technology, proudly announces its expansion into Mexico — one of the fastest-growing markets for aesthetic medicine and plastic surgery procedures worldwide. This marks ELIXIR MD’s 17th global market entry, powered by a strategic partnership with top Mexican plastic surgeons Dr. Leonardo Moreno-Tevizo and Dr. Andrés Bello Cárdenas.
Mexico ranks as the third-largest country for plastic surgery volume, trailing only the USA and Brazil. The country’s aesthetic medicine market reached approximately $2.6 billion in 2024 and is projected to exceed $6 billion by 2030, driven by:
ELIXIR MD’s expansion into Mexico is perfectly timed to meet these rising demands with its proven Photobiomodulation designed exlusively for plastic surgeons.
ELIXIR MD™ delivers innovative, FDA-cleared non-invasive recovery technology that transforms how plastic surgeons manage post-operative care. Key benefits include:
Drs. Moreno-Tevizo and Bello Cárdenas bring ELIXIR MD™ technology to Mexico, empowering local surgeons with tools that enhance outcomes and patient experiences.
Partnering with leading Mexican plastic surgeons ensures ELIXIR MD™ integrates seamlessly into the local aesthetic medicine ecosystem by providing:
Surgeons gain access to the most advanced plastic surgery recovery devices, allowing them to offer:
Patients benefit from less downtime and improved comfort, making ELIXIR MD™ a breakthrough solution in post-surgical healing technology.
With this expansion, ELIXIR MD™ strengthens its commitment to revolutionizing plastic surgery recovery worldwide. Mexico is a critical market where innovative medical devices for post-operative care meet the rising demand for superior aesthetic medicine outcomes.
Surgeons and patients alike will experience the impact of ELIXIR MD™’s patented technology designed to redefine recovery standards in plastic surgery.